2-(4-Chloropyridin-2-yl)-4,4-dimethyl-4,5-dihydrooxazole, 97%, 1g

2-(4-Methoxyphenyl)-5-methyl-1,3,4-oxadiazole, 100mg

4-Tolylacetic acid, 99.0%, 500g

(4-chloro-1H-pyrazol-1-yl)acetonitrile, 95.0%, 100mg

N,N-Dimethyl-1-piperidin-4-ylmethanamine, 95.0%, 5g

?-Cyclodextrin, 95%, 100g

Bis[4-(tert-butyl)phenyl]iodonium Tetra(nonafluoro-tert-butoxy)aluminate>98.0%(HPLC)(T)100mg

2-(Benzyloxy)-1,3,5-trichlorobenzene, 95%, 5g

5-iodo-1-methyl-3-(trifluoromethyl)-1H-pyrazole, 1g

(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate, 95%, 1g

3-tert-butyl-1-(2-nitrophenyl)-1H-pyrazol-5-amine, 95.0%, 2g

2,6-Dimethyl-4-[2-nitro-4-(trifluoromethyl)phenyl]morpholine, 98%, 25g

1-Methyl-4-(piperidin-4-yl)piperazine, 98.0%, 10g